Hormonal regulators of muscle and metabolism in aging (HORMA): Design and conduct of a complex, double masked multicenter trial

Clinical Trials

Volumn 4, Issue 5, 2007, Pages 560-571

  Schroeder, E Todd ^a   Castaneda Sceppa, Carmen ^b   Wang, Ying ^c   Binder, Ellen F ^d   Kawakubo, Miwa ^c   Stewart, Yolanda ^c   Storer, Thomas ^e   Roubenoff, Ronenn ^b   Bhasin, Shalender ^e   Yarasheski, Kevin E ^d   Sattler, Fred R ^c   Azen, Stanley P ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEUTERIUM OXIDE; HUMAN GROWTH HORMONE; ISOTOPE; MUSCLE PROTEIN; TESTOSTERONE;

AGED; AGING; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC IMAGING; DILUTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; DUAL ENERGY X RAY ABSORPTIOMETRY; EDUCATION; ELECTRONICS; EVALUATION; FUNCTIONAL ASSESSMENT; HORMONAL REGULATION; HOSPITAL ADMISSION; HUMAN; INTERNET; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; METABOLISM; MULTICENTER STUDY; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROBLEM SOLVING; PROTEIN DEGRADATION; PROTEIN SYNTHESIS REGULATION; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RESOURCE MANAGEMENT; SAMPLE SIZE; STANDARDIZATION; TESTOSTERONE BLOOD LEVEL; TRAINING; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; AGING; HUMANS; MALE; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE, SKELETAL; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TESTOSTERONE;

EID: 36549016998     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774507083569     Document Type: Article

References (39)

1. Rosenberg IH. Summary comments. Am J Clin Nutr 1989; 50: 1231-33.
2. Holloszy JO. Workshop on sarcopenia: muscle atrophy in old age. J Gerontol Biol Med Sci 1995; 50A: 1-161.
3. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
4. Dutta C, Hadley EC. The significance of sarcopenia in old age. J Gerontol A Biol Sci Med Sci 1995; 50: 1-4.
5. Larsson L, Grimby G, Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol 1979; 46: 451-6.
6. Danneskiold-Samsoe B, Kofod V, Munter J et al. Muscle strength and functional capacity in 78-81-year-old men and women. Eur J Appl Physiol 1984; 52: 310-4.
7. Aniansson A, Grimby G, Hedberg M et al. Muscle morphology, enzyme activity, and muscle strength in elderly men and women. Clin Physiol 1981; 1: 73-86.
8. Bassey EJ, Bendall MJ, Pearson M. Muscle strength in the triceps surae and objectively measured customary walking activity in men and women over 65 years of age. Clin Sci 1988; 74: 85-89.
9. Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998; 147: 750-54.
10. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997; 82: 3793-96.
11. Harman SM, Metter EJ, Tobin JD et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore longitudinal study of aging. J Clin Endocrinol Metab 2001; 86: 724-31.
12. Abbasi AA, Drinka PJ, Mattson DE et al. Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. J Am Geriatr Soc 1993; 41: 975-82.
13. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 1999; 84: 573-77.
14. Baumgartner RN, Waters DL, Gallagher D et al. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999; 107: 123-36.
15. Urban RJ, Bodenburg YH, Gilkison C et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol Endocrinol Metab 1995; 269: E820-26.
16. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092-98.
17. Morley JE, Perry HMd, Kaiser FE et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993; 41: 149-52.
18. Morley JE, Kaiser FE, Sih R et al. Testosterone and frailty. Clin Geriatr Med 1997; 13: 685-95.
19. Rogers MA, Evans WJ. Changes in skeletal muscle with aging: effects of exercise training. Exerc Sport Sci Rev 1993; 21: 65-102.
20. Rudman D, Kutner MH, Rogers CM et al. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361-69.
21. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991; 73: 1081-88.
22. Rudman D, Feller AG, Nagraj HS et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1-6.
23. Gallagher D, Visser M, De Meersman RE et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 1997; 83: 229-39.
24. Roubenoff R, Kehayias JJ. The meaning and measurement of lean body mass. Nutr Rev 1991; 49: 163-75.
25. Watkins JC, Roubenoff R, Rosenberg IH. Body composition: measure and screening of change with age. Foundation for Nutritional Advancement, Boston, MA, 1992.
26. Veldhuis JD, Iranmanesh A, Lizarralde G et al. Combined deficits in the somatotropic and gonadotropic axes in healthy aging men: an appraisal of neuroendocrine mechanisms by deconvolution analysis. Neurobiol Aging 1994; 15: 509-17.
27. Lucidi P, Lauteri M, Laureti S et al. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 1998; 83: 353-57.
28. Toogood AA, Shalet SM. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. J Clin Endocrinol Metab 1999; 84: 131-36.
29. Amato G, Mazziotti G, Di Somma C et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endoainol Metab 2000; 85: 3720-25.
30. Yarasheski KE, Campbell JA, Smith K et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992; 262: E261-267.
31. Yarasheski KE, Zachwieja JJ. Growth hormone therapy for the elderly: the fountain of youth proves toxic. Jama 1993; 270: 1694.
32. Diessel E, Fuerst T, Njeh CF et al. Evaluation of a new body composition phantom for quality control and cross-calibration of DXA devices. J Appl Physiol 2000; 89: 599-605.
33. Yarasheski KE, Smith SR, Powderly WG. Reducing plasma HIV RNA improves muscle amino acid metabolism. Am J Physiol Endocrinol Metab 2005; 288: E278-284.
34. Bassey EJ, Fiatarone MA, O'Neill EF et al. Leg extensor power and functional performance in very old men and women. Clin Sci (Lond) 1992; 82: 321-7.
35. Margaria R, Aghemo P, Rovelli E. Measurement of muscular power (anaerobic) in man. J Appl Physiol 1966; 21: 1662-64.
36. Walsh M, Woodhouse LJ, Thomas SG et al. Physical impairments and functional limitations: a comparison of individuals 1 year after total knee arthroplasty with control subjects. Phys Ther 1998; 78: 248-58.
37. Cunningham DA, Rechnitzer PA, Pearce ME et al. Determinants of self-selected walking pace across ages 19 to 66. J Gerontol 1982; 37: 560-4.
38. Sinha-Hikim I, Arver S, Beall G et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1998; 83: 1312-18.
39. Mauras N, Hayes V, Welch S et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998; 83: 1886-92.